AI-based digital MammaPrint assay predicts recurrence risk and survival in early-stage breast cancer

AI tool identifies patients most likely to benefit from extended endocrine therapy in hormone receptor-positive breast cancer

Harnessing AI and data to predict, personalise and transform cancer care

Using artificial intelligence to improve lung cancer screening and risk prediction

CLL TIM risk model predicts infection and treatment need in newly diagnosed chronic lymphocytic leukaemia

Metronomic chemo plus nivolumab (TMC-I) improves survival in R/M head & neck cancer vs platinum chemotherapy

ASCO 2026: Comment: Multi-cancer earlier detection tests

Mobile app-based symptom monitoring helps maintain quality of life in advanced cancer

Cytoreductive SBRT with ipilimumab and nivolumab in de novo mRCC shows no PFS benefit but is safe

ArteraAI MMAI enhances prediction of biochemical recurrence and metastasis in localised prostate cancer

The Vanessa Moss Prize: celebrating research into cancer health disparities

Improving cancer care by partnering not-for-profits based in the UK and Ireland with colleagues in LMICs